Patent · US Active

Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators

US11214563B2 · kind B2 · utility

2Cited by

14References

26Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Curt A. Dvorak · Poway, US
Heather R. Coate · San Diego, US

Key dates

Filing date	Jun 12, 2020
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Jun 26, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted PYRAZOLO-PYRAZINES as GluN2B receptor ligands. Such compounds may be used in GluN2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by GluN2B receptor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.